FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
On Jul. 10, 2017, the OHSU Knight Cancer Institute was awarded the National Cancer Institute’s premier status: Comprehensive…
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
On May 24, 2017, the National Cancer Institute (NCI) awarded $24 million to Fred Hutchinson Cancer Research Center…
On May 15, 2017, Winship Cancer Institute of Emory University earned the prestigious comprehensive cancer center designation from…
On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…
On Apr. 26, 2017, the University of Virginia Cancer Center was honored as one of just 69 National…
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
On Mar. 3, 2017, Siteman Cancer Center launched the Siteman Cancer Network to improve the health of individuals…
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…
On Sept. 29, 2016, University of Southern California (USC) Trustee Marc Benioff ’86 and his wife, Lynne, gifted…
On Sept. 26, 2016, Washington University School of Medicine in St. Louis announced it had received a $10…
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
On Aug. 31, 2016, State Senator Pat Steadman was honored by the University of Colorado Cancer Center (CU)…
On Aug. 29, 2016, Scripps Health and MD Anderson Cancer Center announced a partnership agreement to create Scripps…
On Jul. 5, 2016, The Stanford Cancer Institute announced it had been designated a Comprehensive Cancer Center by…